4577 — Daito Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for Daito Pharmaceutical Co, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

	2019 May 31st	2020 May 31st	2021 May 31st	2022 May 31st	2023 May 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1,819	3,084	3,373	4,381	3,607
Net Total Accounts Receivable
Net Total Receivables	12,164	15,521	12,791	16,146	17,654
Total Inventory
Total Other Current Assets
Total Current Assets	24,361	30,855	32,430	37,909	40,663
Net Property, Plant And Equipment	18,732	19,400	21,372	23,116	25,837
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	46,749	54,250	57,739	64,939	70,552
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11,618	15,054	12,859	14,069	15,428
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	15,807	17,741	16,120	17,632	19,880
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	30,942	36,509	41,619	47,307	50,672
Total Liabilities & Shareholders' Equity	46,749	54,250	57,739	64,939	70,552
Total Common Shares Outstanding